Powered by: Motilal Oswal
2026-09-08 09:02:12 am | Source: Accord Fintech
Opening Bell : Markets likely to make negative start on Tuesday
Opening Bell : Markets likely to make negative start on Tuesday

Indian equity markets are likely to make a negative start on Tuesday amid cautiousness over the elevated crude oil prices and escalating geopolitical tensions. However, some support may come from Foreign Institutional Investors (FIIs), who turned net buyers on September 7, 2026, purchasing equities worth Rs 280.13 crore. 

Some of the key factors to be watched:

India’s business confidence hits multi-quarter high for Q2FY27: The Confederation of Indian Industry (CII) said India Inc is optimistic about the second quarter of FY27 as disruptions from the West Asia crisis ease gradually and economic momentum is expected to sustain, with the CII Business Confidence Index for April-June rising to 66.0 from 60.8 in the preceding quarter, signalling broad-based improvement in business expectations. 

UK recognises India's carbon credit scheme under its carbon tax mechanism: The report said in a major breakthrough, the UK has recognised India's Carbon Credit Trading Scheme as a qualifying criterion for pricing relief under its carbon border adjustment mechanism (CBAM), a move that would reduce the tax burden on domestic exporters.

Goyal pitches for developing best medical devices for global customers: Commerce and Industry Minister Piyush Goyal has pitched for development of high-quality medical devices for global customers, and said the government is ready to provide 100 per cent fund for the acquisition of testing equipment.

Govt keeps PSB employees' PLI scheme for FY26 in abeyance after union representation: The government has decided to keep in abeyance the implementation of the performance-linked incentive (PLI) scheme for employees of public sector banks (PSBs) for 2025-26 following a representation by bank employees seeking a review of its existing structure. 

NBFC gold loans rise 68.5% in July: The Reserve Bank said loans against gold jewellery by non-banking financial companies (NBFCs) grew at 68.5 per cent in July 2026 in continuation of a months-long trend where high lending against precious metals has been growing at elevated levels.

Global front: The US markets were closed on Monday on account of Labor Day holiday. Asian markets are trading mixed on Tuesday as renewed Middle East tensions kept crude prices elevated, fuelling concerns over inflation and interest rates. 

Back home, Indian equity benchmarks ended lower on Monday as elevated crude oil prices, escalating US-Iran hostilities and concerns over a possible US interest rate hike weighed on investor sentiment. Continued foreign outflows also added pressure to Indian equities. Foreign institutional investors (FIIs) remained net sellers for a second consecutive session, offloading equities worth Rs 3,111.94 crore on Friday. Finally, the BSE Sensex fell 382.62 points or 0.50% to 76,132.81 and the CNX Nifty was down by 118.55 points or 0.50% to 23,779.15.

Some of the important factors in trade: 

India-EU FTA unlocks growth opportunities for farmers, MSMEs, businesses: Commerce and Industry Minister Piyush Goyal has highlighted the transformative opportunities offered by the India- European Union (EU) Free Trade Agreement (FTA) for businesses and stakeholders across India and Europe, noting that the agreement would benefit farmers, fishermen, MSMEs, small industries, innovators, startups, women entrepreneurs, manufacturers and service providers.  

RBI mops up Rs 6.02 lakh crore thorough two VRRR auctions amid record banking system surplus: The Reserve Bank of India (RBI) has absorbed over Rs 6.02 lakh crore from the banking system through two variable rate reverse repo (VRRR) auctions as surplus liquidity remained at a record high. 

Goyal calls for making pharma sector more attractive for investments in clinical trials, R&D: Commerce and Industry Minister Piyush Goyal has called for making the pharmaceutical sector more attractive for investments in clinical trials, patenting products, conducting research and development (R&D) and introducing new products in India.

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here